Charles Schwab’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$474K Buy
+21,013
New +$474K ﹤0.01% 3158
2023
Q3
Sell
-447
Closed -$5.91K 3637
2023
Q2
$5.91K Hold
447
﹤0.01% 3603
2023
Q1
$34.9K Hold
447
﹤0.01% 3418
2022
Q4
$37.2K Hold
447
﹤0.01% 3416
2022
Q3
$42K Hold
447
﹤0.01% 3373
2022
Q2
$67K Hold
447
﹤0.01% 3346
2022
Q1
$109K Hold
447
﹤0.01% 3400
2021
Q4
$136K Buy
447
+204
+84% +$62.1K ﹤0.01% 3410
2021
Q3
$101K Hold
243
﹤0.01% 3380
2021
Q2
$75K Sell
243
-1,472
-86% -$454K ﹤0.01% 3319
2021
Q1
$353K Buy
1,715
+117
+7% +$24.1K ﹤0.01% 3194
2020
Q4
$320K Buy
1,598
+106
+7% +$21.2K ﹤0.01% 3134
2020
Q3
$248K Sell
1,492
-88
-6% -$14.6K ﹤0.01% 3107
2020
Q2
$392K Buy
1,580
+116
+8% +$28.8K ﹤0.01% 2926
2020
Q1
$267K Buy
1,464
+14
+1% +$2.55K ﹤0.01% 2925
2019
Q4
$420K Hold
1,450
﹤0.01% 2888
2019
Q3
$396K Buy
1,450
+243
+20% +$66.4K ﹤0.01% 2889
2019
Q2
$454K Sell
1,207
-1,636
-58% -$615K ﹤0.01% 2853
2019
Q1
$762K Buy
2,843
+165
+6% +$44.2K ﹤0.01% 2633
2018
Q4
$570K Hold
2,678
﹤0.01% 2713
2018
Q3
$1.2M Hold
2,678
﹤0.01% 2564
2018
Q2
$1.09M Buy
2,678
+1,785
+200% +$725K ﹤0.01% 2563
2018
Q1
$487K Buy
893
+173
+24% +$94.3K ﹤0.01% 2736
2017
Q4
$435K Hold
720
﹤0.01% 2758
2017
Q3
$332K Hold
720
﹤0.01% 2840
2017
Q2
$292K Buy
+720
New +$292K ﹤0.01% 2882